IMMUNOTHERAPY: Cancer vaccine triggers antiviral-type defences

    loading  Checking for direct PDF access through Ovid


An immunotherapy approach targets nanoparticles to dendritic cells of the immune system, leading to an antitumour immune response with antiviral-like features. Initial clinical tests of this approach show promise. See Letter p.396

Related Topics

    loading  Loading Related Articles